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ABSTRACT
Ginseng Radix, the dried root of Panax ginseng, is easily confused with other herbs of the Panax species by appearance. In
Chinese medicine preparations, it is difficult to identify misuse of Ginseng Radix. In this study, the nested PCR and DNA
sequencing methods were established for the identification of Ginseng Radix, whereas the combination of nested PCR and restriction fragment length polymorphism (RFLP) could differentiate Ginseng Radix from other Panax species and thus certify the use of
impure raw material of Ginseng Radix in Chinese medicine preparations. Nested PCR and DNA sequencing methods were applied
to verify ginseng ingredients in the preparations. Of the 58 samples analyzed, 48 samples contained P. ginseng, 8 P. quinguefolius,
and 2 P. notoginseng. Utilizing restriction enzyme BstYI and DdeI, nested PCR products of the samples were digested for restriction fragment lengths of polymorphism (RFLP). It was proven that 23 of the 58 samples contained a mixture of Ginseng Radix
and Panacis quinquefolii Radix. Twenty-five samples contained pure raw material of Ginseng Radix. Ginseng components of 10
samples were confirmed using a substitute of P. quinguefolius or P. notoginseng. The RFLP results were consistent with those of the
sequencing method results.
Key words: Panax ginseng, Ginseng Radix, internal transcribed spacer (ITS), nested PCR, DNA sequencing, Restriction Fragment
Length Polymorphism (RFLP)

INTRODUCTION
Ginseng Radix, the dried root of Panax ginseng,
also known as ginseng, is the most popular Chinese
medicinal herb. In an ancient medicinal book, Shen
Nong Ben Cao Jing, written before A.D. 100, ginseng
was used for repairing the five viscera, quieting the
spirit, curbing emotions, stopping agitation, removing
noxious influences, brightening the eyes, enlightening
the mind, and increasing wisdom. Ginseng extracts have
been used as a commercial dietary supplement. Current
research suggests that the main components extracted
from ginseng, ginsenosides, have anti-cancer, immune
modulation(1), antioxidant (2,3), anti-inflammatory(4), antiapoptotic (5), and immunostimulant (6,7) effects on human
health.
The chemical components and appearance of
ginseng differ by habitat. Ginseng is easily confused
* Author for correspondence. Tel: +886-2-2653-1245;
Fax: +886-2-2653-1256; E-mail: kangtzu@fda.gov.tw

with Panacis quinquefolii Radix in appearance. Panacis
quinquefolii Radix, the dried root of P. quinguefolius, is known as American ginseng. Because ginseng
and American ginseng have different pharmacological
effects(8), many chemical and physical methods have
been developed to differentiate ginseng from other
Panax species. For example, molecular spectroscopy,
such as near infrared diffuse reflection spectroscopy,
Raman spectroscopy and infrared spectroscopy, were
used for differentiation among Ginseng Radix, Ginseng
Rubra Radix and Panacis Quinquefolii Radix(9). High
performance thin-layer chromatography (HPTLC)
fingerprint analysis was used for species authentication of Panax ginseng, Panax quinquefolium and Panax
notoginseng (10). Molecular biological methods were
also useful to authenticate ginseng, such as arbitrarily
primed PCR (AP-PCR), random amplified polymorphic
DNA (RAPD), sequence characterized amplified region
(SCAR), direct amplification of length polymorphisms
(DALP), and sequencing(11).
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Ginseng is prepared according to the formulas of
ancient medicinal books published in eastern Asia. Each
formula consists of many different herbs. Because that
all herbs in the formula have lost their appearance after
drying, also the chemical components of the formula are
complex in the preparation. Therefore, it is difficult to
differentiate ginseng from other herbs by physical and
chemical analysis methods.
Because PCR cross-amplifies the DNA of these
herbs, molecular biological methods may have difficulties in identifying ginseng. In our previous study(12), we
were successful in differentiating Achyranthis Bidentatae Radix from Cyathulae Radix by nested PCR and
DNA sequencing methods. Using this method for quality
control and medicinal component testing purposes
require greater budget for auto-sequencing, other necessary equipments, and materials for sequencing. Therefore, a fast and inexpensive method must be developed.
In this study, nested PCR and DNA sequencing methods
were applied to identify ginseng ingredients of preparations. Moreover, nested PCR was combined with restriction fragment lengths of polymorphism (RFLP) to identify P. ginseng in the preparations, and to determine
whether the preparations contain other Panax species.
The combination methodology reduces time, equipment,
and materials costs for the authentication of ginseng, and
has more potential applications in pharmaceutical industries and research institutions

MATERIALS AND METHODS
I. Samples
Fifty-eight samples of Chinese medicinal preparations, with Ginseng noted on the ingredient labels, were
purchased from local traditional Chinese (herbal) pharmacies. Ginseng Radix was collected in Jilin, China,
in July 2002, and was identified by Dr. Lin-Yu Lin of
Chinese Academy of Medical Sciences, Beijing, China.
Panacis quinquefolii Radix was purchased from a local
importer of Chinese herbal medicines in May 2006 and
was authenticated in our laboratory. We deposited the
voucher specimens of Ginseng Radix-A-4-B03 and
Panacis quinquefolii Radix-950011831 at the Chinese
herbal drug specimen room of the Food and Drug
Administration, Taipei, Taiwan, R.O.C.
II. Primers
We amplified the ITS region of Panax species for
preparations by PCR with primers PgF3 (5’-GATCATTGTCGAAACCTGCAT-3’) and PgR (5’-CAGGGTCATGAGAGCTTTTC-3’) and re-amplified the PCR products
by nested PCR with primer PgF1 (5’-CCGCGAACACGTTACAATAC-3’) and PgR3 (5’-GGTCACCGCACGACATGAGA-3’). These two primer pairs were designed

according to the ITS sequences deposited in Genbank,
which included Panax assamicus (AY233321), P. stipuleanatus (U41696), P. trifolius (U41698), P. notoginseng (U41685), P. ginseng (AJ786235), P. japonicus
(AF263373), P. quinquefolius (U41689), P. vietnamensis
(AY271924), P. wangianus (U41691), P. zingiberensis
(U41700) and P. pseudoginseng (AY233327).
III. DNA Extraction
The DNA extraction method was adopted from
our previous research(12). First, the herb samples were
ground by grinders. One hundred milligrams of powder
of all samples was placed in a 2.0-mL micro-centrifuge
tube, digested in 1 mL lysis buffer [ 100 mM Tris-HCl,
pH 8.0, 100 mM EDTA, 1% N-lauroyl sarcosine sodium
salt (sarcosyl), and 1 mg/mL proteinase K] and incubated
at 56°C for 1 hour. The sample solution was extracted
with 1 mL of phenol/chloroform/isoamylalcohol (25:24:1,
v/v/v) mixture solution and centrifuged at 12000 ×g for
5 min. The aqueous layer was mixed with 0.2 mL of 5 M
NaCl and 0.15 mL of 10% hexadecyltrimethylammonium
bromide (CTAB) in 0.7 M NaCl, and further incubated at
65°C for 15 min. The solution was extracted with 1 mL
of chloroform/isoamyl alcohol (24:1, v/v) mixture solution and centrifuged at 12000 ×g for 5 min. The aqueous
solution was then transferred into another 2.0-mL microcentrifuge tube. DNA in the solution was precipitated by
adding 0.7 mL isopropanol and 0.1 mL of 3 M sodium
acetate (pH 5.5). Precipitated DNA was centrifuged at
12000 ×g for 5 min, air-dried, and dissolved in 0.1 mL of
sterile distilled water. A PCR purification kit (QIAGEN
GmbH, Germany) was used to purify the dissolved DNA,
with the silica membrane to absorb DNA through the
high concentration of chaotropic salt in solutions. The
purified DNA product was reserved for further PCR
analysis.
IV. Polymerase Chain Reaction and ITS Fragment
Amplification
Purified DNA was used as the templates for PCR
amplification. Amplification was performed in 50 μL of
solution by incubating 1 μL DNA with 5 μL 10 X Taq
buffer, 0.5 μL of 25 μM PCR primer, 1 μL of 10 mM
dNTP, 2 units of Taq polymerase, and sterilized distilled
water. A control (no template) was included in each reaction. PCR reactions were performed in Astec PC320
(Astec, Fukuoka, Japan) using the following program:
30 sec of denaturation step at 94°C, 30 sec of annealing
step at 62°C, and 30 sec of extension step at 72°C for a
total of 25 cycles. One microliter of the resultant PCR
product was used as a template for nested PCR. Nested
PCR was carried out 25 times, each cycle consists of
an initial DNA denaturation step at 94°C for 30 sec, an
annealing step at 65°C for 30 sec, and an extension step
at 72°C for 30 sec. Five microliters of final PCR products
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were analyzed by electrophoresis in a 1.8% agarose gel.
After electrophoresis in 0.5 X TBE buffer (Tris-Boric
acid-EDTA) at 100 volts for 30 min, the gel was stained
with ethidium bromide (0.5 mg/mL) before being photographed under ultraviolet (UV) illumination.
V. Sequencing
Five microliters of the nested PCR products were
incubated with 2 μL of ExoSAP-IT (USB, OH, USA) at
37°C for 15 min to remove excess dNTP and residual
primers. Afterwards, the mixture was heated at 80°C
for 15 min to inactive the enzymes. One microliter of
the resulting mixture was used for the sequencing reaction using BigDye Terminator v3.1 cycle sequencing kit
(Applied Biosystems, CA, USA). The sequencing reaction was purified by BigDye XTerminator purification kit
(Applied Biosystems, CA, USA), and the sequences were
determined for both strands using 3130 Genetic Analyzer
(Applied Biosystems, CA, USA) and compared with the
sequences in GenBank database.
VI. Restriction Fragment Length Polymorphism
Five microliters of the nested PCR products was
incubated with 2 units of restriction enzyme BstYI at
60°C and 2 units of DdeI (New England BioLabs, MA,
USA) at 37°C for 1 hr, respectively. Five microliters of
the resulting mixture was analyzed by electrophoresis in
a 1.8% agarose gel. After electrophoresis in 0.5 X TBE
buffer (Tris-Boric acid-EDTA) at 100 volts for 30 min,
the gel was stained with ethidium bromide (0.5 mg/
mL) before being photographed under ultraviolet (UV)
illumination. DNA fragments recovered from electrophoresis gel were extracted by QIAquick Gel Extraction kit (QIAGEN GmbH, Germany) and analyzed by
sequencing.

In this study, we found that Panacis quinquefolii
Radix and Notoginseng Radix are misused as Ginseng
Radix in these samples. Notoginseng Radix is the dried
root of P. notoginseng that is used to stop bleeding and
has different medicinal effects from Ginseng Radix. The
designed primer sets could be used to amplify the DNA
of eleven herbs of the Panax species at the same time.
PCR products may contain two kinds of DNA; however,
it was difficult to distinguish the differences by electrophoresis and sequencing results. The results of ginseng
ingredient identified by sequencing methods could only
prove that the preparation samples contained more than
one Panax species. Therefore, another method was
needed to differentiate the mixed Panax species in the
samples.
This study analyzed the ITS sequence of eleven
Panax species collected from GenBank to determine
the appropriate recognition sites of restriction enzymes
for discriminating P. ginseng from other Panax species.
The restriction enzyme BstYI could cut the amplified ITS
fragment of P. ginseng and P. japonicus, and DdeI only
cut the one of P. japonicus but not the ITS sequences of
the other Panax species. In other words, if the amplified ITS fragment can be cut by BstYI but not by DdeI, it
means the sample only contained P. ginseng.
Each nested PCR product of the examined samples
was tested separately with restriction enzyme BstYI
and DdeI. RFLP patterns could identify whether the
samples contain pure ingredients of Ginseng Radix. The
nested PCR products of all preparation samples were first
treated with DdeI. No PCR products were cut by DdeI,
indicating that no samples contained P. japonicus. The
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RESULTS AND DISCUSSION
The most commonly misused herb for Ginseng
Radix is Panacis quinquefolii Radix. The ITS sequences
of raw material samples of Ginseng Radix and Panacis
quinquefolii Radix were analyzed and compared with the
sequences in GenBank data to confirm the two samples
as P. ginseng and P. quinguefolius, respectively. The
two samples were then used as standard herbs for the
following tests. By applying the designed primer sets in
nested PCR, the DNA of all preparation samples could
be amplified. The electrophoresis pattern is showed in
Figure 1. The sequence data of the nested PCR products were obtained to identify which herb of the Panax
species was in the preparation sample. The results are
listed in Table 1. Among the 58 samples, 48 samples
contained P. ginseng, 8 contained P. quinguefolius, and 2
contained P. notoginseng.

600
500

528 bp

Figure 1. Nested PCR products of Ginseng Radix and preparation
samples.
Lane 1: 100 bp ladder marker; Lane 2: Ginseng Radix; Lane 3:
Pg1A; Lane 4: Pg2B; Lane 5: Pg9E; Lane 6: TC-C; Lane 7: blank (no
template).
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Table 1. The results of ginseng ingredient identification and RFLP from sample preparations
Preparation

Sample Number

Identified Ingredient by
DNA sequencing method

Cut number of RFLP*

Jen-Shen-Bai-Du-Tang

Pg1A

P. ginseng

2

Liu-Ho-Tang

Pg2A

P. ginseng

2

Pg2B

P. ginseng

2

Pg3A

P. ginseng

2

Pg3B

P. ginseng

1

Pg3C

P. ginseng

1

Pg3E

P. quinguefolius

0

Pg3F

P. ginseng

1

Chai-Ham-Tang

Pg4A

P. ginseng

2

Ching-Tsao-Chiu-Fei-Tang

Pg5B

P. ginseng

1

Sheng-Su-Yin

Pg6A

P. ginseng

2

Pg6B

P. ginseng

1

Pu-Ji-Xiao-Du-Yin

Pg7A

P. ginseng

2

Wen-Jing-Tang

Pg8B

P. ginseng

1

Pu-Chung-I-Chi-Tang

Pg9A

P. ginseng

2

Pg9B

P. ginseng

1

Pg9C

P. ginseng

1

Pg9E

P. quinguefolius

0

Pg9F

P. notoginseng

0

Pan-Hsia-Pai-Chu-Tien-Ma-Tang

Tu-Huo-Chi-Sheng-Tang

Pg10B

P. ginseng

1

Jen-Shen-Yang-Rong-Tang

Pg11A

P. ginseng

2

Pg11B

P. ginseng

1

Pg11C

P. ginseng

1

Pg11E

P. ginseng

2

Pg11F

P. quinguefolius

0

Pg12A

P. ginseng

2

Pg12B

P. ginseng

1

Pg12C

P. quinguefolius

0

Pg12D

P. ginseng

1

Pg12E

P. ginseng

2

Pg12F

P. quinguefolius

0

Hsiao-Hsu-Ming-Tang

Pg13B

P. ginseng

1

Ten-Wang-Pu-Hsin-Tan

Pg14A

P. ginseng

2

Pg14B

P. ginseng

1

Pg14D

P. ginseng

1

Pg15A

P. ginseng

2

Pg15B

P. ginseng

2

San-Bi-Tang

Sheng-Mai-San
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Table 1. Continued
Preparation

Identified Ingredient by
DNA sequencing method

Sample Number

Cut number of RFLP*

Ding-Zhi-Wan

Pg16A

P. ginseng

2

Fu-Tzu-Li-Chung-Tang

Pg17A

P. ginseng

2

Pg17B

P. ginseng

2

Pg17D

P. ginseng

1

Pg18A

P. ginseng

2

Pg18B

P. ginseng

1

Pg18C

P. ginseng

1

Pg18D

P. ginseng

1

Pg19A

P. ginseng

2

Pg19B

P. ginseng

2

Pg19C

P. quinguefolius

0

Pg19D

P. ginseng

1

Pg20A

P. ginseng

2

Pg20B

P. ginseng

1

Pg21A

P. ginseng

2

Pg21B

P. ginseng

1

Pg21C

P. quinguefolius

0

TC-B

P. ginseng

1

TC-C

P. notoginseng

0

TC-E

P. ginseng

1

TC-F

P. quinguefolius

0

Sang-Piao-Hsiao-San

Ching-Chu-I-Chi-Tang

Tzu-Wen-Tang

Yang-Hsin-Tang

Kuei-Lu-Erh-Hsien-Chiao

* “1” indicates that the product of nested PCR can be completely cut by restriction enzyme BstYI, “2” indicates that the product can be cut
into three DNA fragments, and “0” indicates that the product can not be cut.

results of the nested PCR products treated with BstYI
are shown in Figure 2. The size of the nested PCR products amplified from all samples was about 528 bp. The
nested PCR products of Panacis quinquefolii Radix could
not be cut by BstYI, while one Ginseng Radix was cut
into two fragments of about 90 bp and 438 bp. If a sample
contained Ginseng Radix and other Panax species, the
RFLP pattern showed three DNA fragments of 90 bp, 438
bp, and 528 bp, suggesting that the sample contained both
Ginseng Radix and Panacis quinquefolii Radix.
The RFLP results by BstYI are also shown in Table
1. Twenty-three out of 58 samples presented three fragments in the electrophoresis pattern. The uncut fragment was recovered from electrophoresis gel, and then
analyzed by sequencing. The sequences of the fragments
of all 23 samples were confirmed as Panax quinguefolius. The raw materials of Ginseng Radix might be mixed
with Panacis quinquefolii Radix in the 23 samples. Ten
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8. 9. 10. 11. 12. 13. 14.

bp
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400
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100
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Figure 2. RFLP of the nested PCR products of Ginseng Radix,
Panacis quinquefolii Radix and preparation samples digested with
BstYI.
Lane 1: 100 bp ladder marker; Lane 2: Panacis quinquefolii Radix;
Lane 3: Ginseng Radix; Lane 4: Pg1A; Lane 5: Pg2A; Lane 6: Pg4A;
Lane 7: Pg2B; Lane 8: Pg3B; Lane 9: Pg5B; Lane 10: Pg15B; Lane
11: Pg12C; Lane 12: Pg12D; Lane 13: Pg9E, Lane 14: Pg11E.
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samples of preparation showed only one fragment after
BstYI treatment, and the fragments were recovered and
analyzed by sequencing methods to show they belong
to P. quinguefoliu and P. notoginseng. Therefore, we
predicted Ginseng Radix was replaced with Panacis
quinquefolii Radix or Notoginseng Radix in these preparation samples. The ITS of the remaining 25 samples
were cut into two fragments of 90 bp and 438 bp to
assure that it contained only Ginseng Radix. The RFLP
results corresponded to that of the DNA sequencing
method.
The molecular biological methods of nested PCR,
DNA sequencing methods, and RFLP are useful techniques for quality control in pharmaceutical industries
and medicinal component testing for researchers. These
methods can also be applied in post-market inspections
for official management. In this study, we combined the
methods of nested PCR and RFLP to examine the presence of mixed Panax species in herb ingredients of
preparation samples and found that Panacis quinquefolii
Radix was substituted for Ginseng Radix in 31 out of
58 examined samples. The result was verified by DNA
sequencing method, indicating the combination of nested
PCR and RFLP methods is a reliable system to differentiate Ginseng Radix from other Panax species.
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